In this issue of AHPA Report:

Special topic:

FDA warning letters dive into detail by Anthony Young, Esq., Kleinfeld, Kaplan & Becker LLP and AHPA General Counsel

Plus:

• AHPA submits comments on pre-DSHEA dietary ingredients list

• AHPA participates in CIR panel discussion on 4 herbal ingredients

• Industry coalition: Dietary supplements cannot claim to treat opioid addiction

• AHPA mourns the passing of Jim Duke
  ...and much more!